欢迎来到麦多课文档分享! | 帮助中心 海量文档,免费浏览,给你所需,享你所想!
麦多课文档分享
全部分类
  • 标准规范>
  • 教学课件>
  • 考试资料>
  • 办公文档>
  • 学术论文>
  • 行业资料>
  • 易语言源码>
  • ImageVerifierCode 换一换
    首页 麦多课文档分享 > 资源分类 > PPT文档下载
    分享到微信 分享到微博 分享到QQ空间

    Introduction to Anti-inflammatory Drugs.ppt

    • 资源ID:376627       资源大小:1.59MB        全文页数:43页
    • 资源格式: PPT        下载积分:2000积分
    快捷下载 游客一键下载
    账号登录下载
    微信登录下载
    二维码
    微信扫一扫登录
    下载资源需要2000积分(如需开发票,请勿充值!)
    邮箱/手机:
    温馨提示:
    如需开发票,请勿充值!快捷下载时,用户名和密码都是您填写的邮箱或者手机号,方便查询和重复下载(系统自动生成)。
    如需开发票,请勿充值!如填写123,账号就是123,密码也是123。
    支付方式: 支付宝扫码支付    微信扫码支付   
    验证码:   换一换

    加入VIP,交流精品资源
     
    账号:
    密码:
    验证码:   换一换
      忘记密码?
        
    友情提示
    2、PDF文件下载后,可能会被浏览器默认打开,此种情况可以点击浏览器菜单,保存网页到桌面,就可以正常下载了。
    3、本站不支持迅雷下载,请使用电脑自带的IE浏览器,或者360浏览器、谷歌浏览器下载即可。
    4、本站资源下载后的文档和图纸-无水印,预览文档经过压缩,下载后原文更清晰。
    5、试题试卷类文档,如果标题没有明确说明有答案则都视为没有答案,请知晓。

    Introduction to Anti-inflammatory Drugs.ppt

    1、Introduction to Anti-inflammatory Drugs,Weiping Zhang Department of Pharmacology Zhejiang University School of Medicine,2012.10,Peripheral mechanisms of pain,Classification of anti-inflammatory drugs,non-steroid anti-inflammatory drugs (NSAIDs)(Antipyretic-Analgesic and Anti-inflammatory Drugs)解热-镇痛

    2、-抗炎药eg. aspirin, acetaminophen, indomethacin, COX inhibitor, ibuprofen(2) Steroid anti-inflammatory drugsglucocorticoids: eg. dexamethasone (3) 5-LOX inhibitors and leukotriene receptor antagonistsZafirlukast, zileuton,NSAIDs are just that - drugs that act to relieve inflammation, but are not struct

    3、urally related to the corticosteroids,1. The classification of NSAIDs,2. The mechanisms of NSAIDs,2. The mechanisms of NSAIDs,2. The mechanisms of NSAIDs,Cyclooxygenases: COX 1, COX 2,- PGs, mostly by COX-1, are constitutively expressed in almost all tissues; COX-2 appears to only be constitutively

    4、expressed in the brain, kidney, bones, reproductive organs, and some neoplasms- Under normal physiologic conditions, PGs play an essential homeostatic role in cytoprotection of gastric mucosa, hemostasis, renal physiology, gestation, and parturitionIn platelets there is only COX-1exist (converts ara

    5、chidonic acid to TxA2)- COX-1 predominant in gastric mucosa (source of cytoprotective PGs)- The production of PGs, (inducible COX-2 activity COX-1) at sites of inflammation propagate pain, fever,2. The mechanisms of NSAIDs,NSAID inhibition of PG production alleviates most of the pathologic effects a

    6、ssociated with inflammation, but it also interferes with the physiologic role of these molecules Consequently, long-term therapy with nonspecific NSAIDs is frequently limited by their adverse effects, particularly those caused by erosion of gastric mucosal protection, GI bleeding,2. The mechanisms o

    7、f NSAIDs,3. Pharmacodynamic Effects of NSAIDs,Positive Analgesic (0.3-0.6 g/day) - refers to the relief of pain by a mechanism other than the reduction of inflammation (for example, headache); - produce a mild degree of analgesia which is much less than the analgesia produced by opioid analgesics su

    8、ch as morphineanti-inflammatory (3-5 g/day) - these drugs are used to treat inflammatory diseases and injuries, and with larger doses - rheumatoid disordersantipyretic (0.3-0.6 g/day) - reduce fever; lower elevated body temperature by their action on the hypothalamus; normal body temperature is not

    9、reducedantiplatelet (30-100 mg/day)- inhibit platelet aggregation, prolong bleeding time; have anticoagulant effects,antipyretic : compared with chlorpromazine,NSAIDs,Chlorpromazine,Effects,Clinical usage,Side effects,GI reactions,no addiction,Lower the abnormal high temperature to normal. Used for

    10、various fever.,artificial hibernation, Hypothermic anesthesia,Extrapyramidal effects,Inhibit PGs synthesis and enhance thermolysis,Inhibit thermotaxic center in hypothalamus. The body temperature change according to the environment.,3. Pharmacodynamic Effects of NSAIDs,Analgesic : compared with Opio

    11、ids,3. Pharmacodynamic Effects of NSAIDs,Anti-inflammatory: compared with glucocorticoid,3. Pharmacodynamic Effects of NSAIDs,NSAIDs and Platelets/Endothelial Cells,3. Pharmacodynamic Effects of NSAIDs,Reduces platelet aggregationMost of these drugs will potentiate the action of oral anticoagulants

    12、such as coumadin, by their effects on platelet aggregationAn 80 mg dose will increase bleeding time for 2 folds,NSAIDs and Platelets/Endothelial Cells,Note: Selective inhibition of COX-2 will inhibit the production of PGI2 but not of thromboxaneA2, which is produced by COX-1. SO ?,3. Pharmacodynamic

    13、 Effects of NSAIDs,Negative or adverse effectsGastric irritantDecreased renal perfusionBleeding,4. Adverse Effects associated with NSAIDsNon-selective,For patients presenting to hospital with upper gastrointestinal (UGI) bleeding - a significant percent were using NSAIDs,Note: OTC use of NSAIDs was

    14、more prevalent than was prescribed NSAID usage,4. Adverse Effects associated with NSAIDsGastrointestinal reactions,NSAIDs - Gastric Irritant Effects: Molecular Mechanisms,PGs reduce H+ secretion and increase mucous production Consequently, NSAIDs cause some degree of gastric upset due to inhibition

    15、of PG synthesis,- Misoprostol. a synthetic prostaglandin analogue, can also decrease the risk of NSAID-induced ulceration and complications,- PPIs can reduce the risk of peptic ulcer formation,4. Adverse Effects associated with NSAIDs,Afferent arteriole,Efferent arteriole,ACEI/ ARB,NSAIDS, Low volum

    16、e Poor renal perfusion,normal,4. Adverse Effects associated with NSAIDs,NSAIDs Effects on Renal Function,PGs not participated,PGs vasodilator when angiotensin II or catercholamines elevated,5. Drug interactions,丙磺舒 苯磺唑酮,胆红素 苯妥英 萘普生 戊硫代巴比妥 甲状腺素,Salicylates - aspirin,History - Salicylates,Salicylates

    17、were first discovered when the observation was made that chewing willow bark could relieve pain Hippocrates: Willow bark as a pain killer during childbirth Stone (1700) Extract of willow bark to reduce fever Piria (1838) Isolation of salicin from willow bark Kolbe (1853) Synthesis of salicylate (水杨酸

    18、盐) from salicin (水杨苷)Von Gerhardt at Beyer Pharmaceutical Co. synthesized acetyl SA (ASA) in 1850 Hoffman, at Beyer gave ASA to his rheumatoid father Beyer started sales of Aspirin in1899Acetylsalicylic acid (aspirin) was introduced as a pain reliever in 1899, at that time it was used in doses of 65

    19、0 mg every 4 hours,History - Salicylates,Aspirin-Mechanism of Action: Covalent Binding to COX,ASA covalently and irreversibly modifies both COX-1 and COX-2 by acetylating serine-530 in the active siteAcetylation results in a steric block, preventing arachidonic acid from binding,Note: Acetylation of

    20、 COX-2 retains the COX activity although the reaction produces a different product, 15-R-HETE,Aspirin Metabolism Pathways,acetylsalicylic acid (ASA),ASA: t1/2 20 min,salicylate t1/2 3-5 hrs,irreversible acetylation of COX,- Salicylate elimination is 1st order at low and moderate doses; - When total

    21、body salicylate 600mg (3.5g/d), elimination is zero order,酯类和葡醛酸葡糖乙酯,龙胆酸,水杨酸甘氨酸,Aspirin,Dose-Dependent Effects: Low: 300mg blocks platelet aggregationIntermediate: 300-2400mg/day antipyretic and analgesic effectsHigh: 2400-4000mg/day anti-inflammatory effects,Salicylism,Side effects of aspirin,Gastr

    22、ointestinal symptoms CNS toxicity Allergic reaction (urticaria(荨麻疹), angioneurotic edema, aspirin asthma, occasionally anaphylactic shock) Salicylate reaction (CNS reaction) Renal damage Hematologic effects Metabolic acidosis stimulates medullary respiratory center respiratory alkalosis,Salicylism (

    23、水杨酸反应)dose 5g/d: CNS symptoms, including mental confusion; hyperventilation.Rescure: i.v. NaHCO3 promote the excretionHepatic damage Overdose: hepatic damage Reyes syndrome(瑞夷综合征) (kids)severe hepatic damage (严重的肝损害) and encephalopathy (脑病),4. Adverse Effects associated with NSAIDs,NSAIDs: Classific

    24、ation by half-life,Plasma Elimination Half Lives Short Half Life ( 10 hours): slower onset of effect and slower clearance Naproxen (萘普生) (14 2 hrs) Sulindac (舒林酸) (14 8 hrs), Piroxicam (吡罗昔康) (57 22 hrs),Sleisenger & Fordtrans Gastrointestinal and Liver Disease, 8th ed., Copyright 2006 Saunders, An

    25、Imprint of Elsevier,NSAIDs: Classification by COX selection Non-specific inhibition of COX-1 results in gastrointestinal and platelet side effects,In vitro assessment of COX-1 COX-2 activity,Summary of COX-1 vs COX-2 Inhibition,COX-1 compared to COX-2,COX-2 selective inhibitors are generally larger

    26、molecules than NSAIDs and therefore preferentially inhibit COX-2 compared to COX-1 because the hydrophobic channel of COX-2 is larger. That is, COX-2 selective inhibitors are too bulky to access the binding pocket of the COX-1 enzyme,COX-2 Selective Drugs,COX-2 can be up-regulated in the CNS and pla

    27、ys an essential role in the mediation of pain and the febrile response,Patients with rheumatoid arthritis were treated with celecoxib (100, 200, or 400 mg twice daily), naproxen 500 mg twice daily, or a placebo for 12 weeks. Rates of gastroduodenal ulceration with naproxen were statistically higher

    28、(*P 0.01) than rates with celecoxib or a placebo. (Data from Simon LS, Weaver AL, Graham DY, et al: Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis. JAMA 282:19211928, 1999.),Incidence of endoscopic gastroduodenal ulcers with a COX-2 specific inhibitor Celec

    29、oxib (赛来考昔),Celecoxib is now the only selective COX-2 inhibitor available in the US- withdrawal of rofecoxib (Vioxx, Merck & Co) Sept 2004- suspension of valdecoxib (Bextra, Pfizer) Apr 2005,Note: The fact that it now carries exactly the same warning for gastrointestinal risk as the older nonselecti

    30、ve NSAIDs is quite remarkable, new drugswere supposedly less risky to the gastrointestinal tract than the older nonselective agents,Celecoxib includes a boxed warning, highlighting the potential for increased risk of cardiovascular events and the well described, serious, potential life-threatening g

    31、astrointestinal bleeding associated with their use.,Celecoxib: Current Status,Celecoxib: cardiovascular events,Celecoxib compared with placebo is not associated with an increased risk for cardiovascular events for duration of use from 12 to 52 weeks. Celecoxib compared with nonselective NSAIDs is no

    32、t associated with increased cardiovascular endpoints.,Acetaminophen (对乙酰氨基酚),analgesia antipyretic no significant anti-inflammatory effects no gastric irritation no platelet function interference half life 2 3 h weak inhibitor of COX-1, -2; not contraindicated for asthma not associated with Reyes Sy

    33、ndrome - The major concern regarding the use of acetaminophen is the potential for high doses to cause liver toxicity,Differences between NSAIDs and Acetaminophen,indomethacin 吲哚美辛stronger efficacy, controlling special types of fever; severe adverse effects Sulindac 舒林酸Its metabolite possess 500 fol

    34、d PG inhibition than itself.Strong anti-inflammation and lower adverse effects than indomethacin. Etodolac 依托度酸Used as a pain killer after operation Lower GI upset,Tolmetin 托美丁Moderate anti-inflammation and mild analgesic and antipyretic effect ibuprofen 布洛芬(芬必得)stronger antipyretic, analgesic and a

    35、nti-inflammatory effects; weaker GI reactions; vision damagepiloxicam 吡罗昔康:long-acting anti-inflammatory and analgesic agent; long-term use induces hemorrhage and ulcers in GI tract,COX-2 selective anti-inflammatory drugs,Meloxicam 美洛昔康,stronger effect on COX-2 than COX-1 long-acting (t1/2 20 h) wea

    36、ker GI reactions,TNF- inhibitor,Etanercept (伊那西普) Infliximab (英夫西单抗) Adalimumab (阿达木单抗),They are recombinant proteins that can not orally taken; The long-term safety is not determined.,References,Basic & Clinical Pharmacology (11th edition), 2010. Goodman & Gilmans the pharmacological basis of therapeutics (12th), 2010. 人民卫生出版社,药理学(第2版),2010,


    注意事项

    本文(Introduction to Anti-inflammatory Drugs.ppt)为本站会员(eveningprove235)主动上传,麦多课文档分享仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。 若此文所含内容侵犯了您的版权或隐私,请立即通知麦多课文档分享(点击联系客服),我们立即给予删除!




    关于我们 - 网站声明 - 网站地图 - 资源地图 - 友情链接 - 网站客服 - 联系我们

    copyright@ 2008-2019 麦多课文库(www.mydoc123.com)网站版权所有
    备案/许可证编号:苏ICP备17064731号-1 

    收起
    展开